Mayo Clinic Comprehensive Cancer Center

Mayo Clinic thoracic surgeons have begun using a single-port robotic system for surgeries that was recently cleared by the Food and Drug Administration (FDA).

A neuro-oncologist at the Mayo Clinic reveals the telltale signs of a “classic brain tumor headache” and other brain tumor symptoms she looks for in her own body.

Rosa Rademakers, Ph.D., a neurogeneticist whose work at Mayo Clinic led to a landmark finding in neurodegenerative disease, has been awarded the 2026 Breakthrough Prize in Life Sciences for the discovery of the most common genetic cause of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), which charted the path for new mechanistic studies of these diseases.

Mayo Clinic researchers developed an experimental nanotherapy that delivers two cancer drugs directly to brain tumors.

A five-year, multisite Mayo Clinic study finds high diagnostic accuracy, low complication rates — and a shift toward earlier-stage detection.

Mayo Clinic researchers have demonstrated that chemotherapy can be safely delivered in patients' homes.

Mayo Clinic Comprehensive Cancer Center is expanding surgical options for patients undergoing treatment or risk-reducing procedures for breast cancer through the adoption of robotic nipple-sparing mastectomy at its Minnesota and Florida campuses.

Dr. Roxana Dronca discusses her Cancer Care Beyond Walls program to administer in-home chemotherapy infusions or injections.

With the help of a dedicated care team and precise treatment, Judge Audrey Moran is back on the bench after facing breast cancer.

Mayo Clinic is bringing new hope for patients diagnosed with the most aggressive and treatment-resistant cancers.